| scholarly article | Q13442814 |
| P50 | author | Luis M Torres | Q56462101 |
| P2093 | author name string | Diego Benitez | |
| Enrique Calderón | |||
| Michael Perelman | |||
| Jose M Trinidad | |||
| P2860 | cites work | Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer | Q37701842 |
| Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer. | Q39201338 | ||
| Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study. | Q39256721 | ||
| Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain. | Q39270863 | ||
| A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain | Q39280743 | ||
| Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief | Q39324051 | ||
| Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip | Q39670017 | ||
| A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain | Q44272068 | ||
| Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management. | Q45994501 | ||
| Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies | Q48294458 | ||
| Breakthrough pain: characteristics and impact in patients with cancer pain. | Q51089873 | ||
| Episodic (Breakthrough) Pain Prevalence in a Population of Cancer Pain Patients. Comparison of Clinical Diagnoses With the QUDEI—Italian Questionnaire for Intense Episodic Pain | Q57758048 | ||
| Breakthrough pain: definition, prevalence and characteristics | Q33435886 | ||
| Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. | Q34251507 | ||
| The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. | Q37245357 | ||
| P433 | issue | 3 | |
| P921 | main subject | fentanyl | Q407541 |
| P304 | page(s) | 114-116 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | International Journal of Palliative Nursing | Q15763040 |
| P1476 | title | Fentanyl pectin nasal spray for breakthrough cancer pain | |
| P478 | volume | 21 |
Search more.